Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.4 | 4e-08 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |